JPRN-UMIN000022873尚未招募3 期
Study of glucocorticoid-induced osteoporosis prevention in patients with glomerulonephritis - Study of glucocorticoid-induced osteoporosis prevention in patients with glomerulonephritis
适应症
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Cases where no consent is obtained. 2.Patients allergic to alendronate sodium or denosumab. 3.Patients pregnant or potential. 4.Other cases where physicians regard as inappropriate.
研究者
相似试验
已完成
不适用
Glucocorticoid-Induced Osteoporosis Treated with Bisphosphonate and DenosumabGlucocorticoid-Induced OsteoporosisJPRN-UMIN000014341Department of Connective Tissue Diseases, Tokyo Medical Center, National Hospital Organization100
已完成
不适用
Eldecalcitol for GLucocorticoid induced OsteopoRosIs versus AlfacalcidolGlucocorticoid-induced osteoporosisJPRN-UMIN000011700e-GLORIA trial Protocol Review Committee (Executive Committee)373
已完成
不适用
Steroid-Induced Osteoporosis in the Pediatric Population - Canadian Incidence StudyRheumatismAcute Lymphoblastic LeukemiaNephrotic SyndromeNCT01663129Children's Hospital of Eastern Ontario406
已完成
3 期
Prevention of Glucocorticoid-Induced Osteoporosis in Rheumatic Diseases: Alendronate Versus Alfacalcidol.Wegener's GranulomatosisPolymyositisRheumatoid ArthritisPolymyalgia RheumaticaGiant Cell ArteritisNCT00138983UMC Utrecht200
已完成
2 期
Can Parathyroid Hormone Injections Reverse Glucocorticoid-induced OsteoporosisOsteoporosisNCT00004993National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)